Oncology round-up: CAR-T conference raises hopes for solid tumour therapy

Kisaco Research’s CAR-T Congress EU could not have come at a better time – the day after it finished NICE announced it had granted funding for a new use for Novartis’ cancer cell therapy Kymriah in lymphoma.